Compare TYG & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TYG | ARDX |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 891.7M | 975.9M |
| IPO Year | 2003 | 2014 |
| Metric | TYG | ARDX |
|---|---|---|
| Price | $40.02 | $3.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.14 |
| AVG Volume (30 Days) | 127.6K | ★ 3.9M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | ★ 11.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,607,000.00 |
| Revenue This Year | N/A | $37.75 |
| Revenue Next Year | N/A | $34.24 |
| P/E Ratio | $52.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.92 | $3.33 |
| 52 Week High | $51.18 | $8.40 |
| Indicator | TYG | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 28.55 | 33.22 |
| Support Level | N/A | $3.33 |
| Resistance Level | $44.39 | $3.92 |
| Average True Range (ATR) | 0.82 | 0.13 |
| MACD | -0.34 | 0.03 |
| Stochastic Oscillator | 4.37 | 18.80 |
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.